Source:http://linkedlifedata.com/resource/pubmed/id/18353095
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-3-20
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1399-3062
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
149-50
|
pubmed:meshHeading |
pubmed-meshheading:18353095-Animals,
pubmed-meshheading:18353095-Antifungal Agents,
pubmed-meshheading:18353095-Azoles,
pubmed-meshheading:18353095-Humans,
pubmed-meshheading:18353095-Mycoses,
pubmed-meshheading:18353095-Paecilomyces,
pubmed-meshheading:18353095-Transplantation,
pubmed-meshheading:18353095-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
New azoles as first line therapy for Paecilomyces lilacinus in transplant patients.
|
pubmed:publicationType |
Letter,
Comment
|